Expected Moves

Q4 FY26 results and initial FY27 guidance will show whether Brady can offset any tariff or macro headwinds with pricing power, mix and cost control. From a base case around $80.00, evidence of sustained mid-single- to high-single-digit organic growth and stable margins could support a recovery toward $86.00, while cautious FY27 guidance or incremental cost pressure could push the stock down toward $86.00 as the earnings multiple compresses closer to sector averages.

Q3 FY26 results and a refreshed FY26 outlook will be the next read on whether Brady can sustain high-single-digit revenue growth and double-digit EPS growth while managing industrial demand and input costs. With the stock at $83.78, a solid print and steady guidance could support a move toward $89.50, while any sign of slowing orders or margin pressure could pull the shares back toward $89.50 as investors reassess the premium to industrial peers.

Brady continues to invest in new labeling systems, RFID and software-driven safety solutions that support workplace automation and regulatory compliance. Successful launches and early adoption signals could help the stock trade up toward $92.00 as investors credit higher-margin growth opportunities, while underwhelming uptake or pricing pressure could see the shares drift back toward $92.00 as the market questions the pace of Brady’s product-driven growth.

Into early 2027, Brady is likely to provide an update on capital allocation, including the balance between buybacks, dividends and potential bolt-on acquisitions in safety and identification niches. If management deploys cash into accretive deals or a clearly articulated capital return framework, the stock could trend toward $88.00; an expensive or poorly framed acquisition, or a lack of deployment clarity, could weigh on sentiment and pull the stock toward $88.00.

Q1 FY27 results will be the first detailed read on whether Brady’s FY27 guidance is realistic and how demand, pricing and costs are tracking in the new fiscal year. If orders remain healthy, pricing holds and any M&A contributions are visible, the stock could push toward $95.00; if industrial demand slows, tariffs bite or new products under-deliver, the shares could retreat toward $95.00 as investors reset expectations.